Here she comes!! http://finance.yahoo.com/news/pl
Post# of 151
(Total Views: 4926)
Posted On: 04/17/2017 12:54:24 PM
Here she comes!!
http://finance.yahoo.com/news/plandai-biotech...rc=applewf
Our subsidiary, Protext Mobility, will soon begin a human study on the island of Mauritius using Phytofare® to regulate glucose levels in Type 2 Diabetics. Mauritius was selected as the trial site because, according to the World Health Organization, the prevalence of Type 2 Diabetes in Mauritius, in 2015, was a world-leading 16.28%. Worldwide, as of 2013, 382 million people, or 8.3% of the adult population have diabetes. The trial protocols are being finalized with a goal to commence the study by mid-summer 2017.
"Protext Mobility, through its subsidiary Cannabis Biosciences Inc., is expecting to shortly receive a research and development license to establish a platform for producing non-psychoactive cannabis. The company plans to produce a Phytofare® complex containing bioavailable cannabinoids, cannabinoid acids, and polyphenols that will be formulated into an oral delivery system. Part of the protocol will be to establish that the Phytofare® complex is non-psychoactive and thereby seek a change in the classification that will allow open and global availability of the product.
Invest for the long haul at E*TRADE.Advertisement
http://finance.yahoo.com/news/plandai-biotech...rc=applewf
Our subsidiary, Protext Mobility, will soon begin a human study on the island of Mauritius using Phytofare® to regulate glucose levels in Type 2 Diabetics. Mauritius was selected as the trial site because, according to the World Health Organization, the prevalence of Type 2 Diabetes in Mauritius, in 2015, was a world-leading 16.28%. Worldwide, as of 2013, 382 million people, or 8.3% of the adult population have diabetes. The trial protocols are being finalized with a goal to commence the study by mid-summer 2017.
"Protext Mobility, through its subsidiary Cannabis Biosciences Inc., is expecting to shortly receive a research and development license to establish a platform for producing non-psychoactive cannabis. The company plans to produce a Phytofare® complex containing bioavailable cannabinoids, cannabinoid acids, and polyphenols that will be formulated into an oral delivery system. Part of the protocol will be to establish that the Phytofare® complex is non-psychoactive and thereby seek a change in the classification that will allow open and global availability of the product.
Invest for the long haul at E*TRADE.Advertisement
(1)
(0)ProText Mobility, Inc. (TXTM) Stock Research Links
Scroll down for more posts ▼